• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

要点:女性对于唐氏综合征无创产前检测知情决策的信息需求

Talking Points: Women's Information Needs for Informed Decision-Making About Noninvasive Prenatal Testing for Down Syndrome.

作者信息

Dane Aimée C, Peterson Madelyn, Miller Yvette D

机构信息

School of Natural Sciences, Griffith University, Brisbane, QLD, 4069, Australia.

Queensland Centre for Mothers & Babies, Building 96, The University of Queensland, Hood Street, St Lucia, QLD, 4072, Australia.

出版信息

J Genet Couns. 2018 Sep;27(5):1258-1264. doi: 10.1007/s10897-018-0250-8. Epub 2018 Mar 17.

DOI:10.1007/s10897-018-0250-8
PMID:29550971
Abstract

Adequate knowledge is a vital component of informed decision-making; however, we do not know what information women value when making decisions about noninvasive prenatal testing (NIPT). The current study aimed to identify women's information needs for decision-making about NIPT as a first-tier, non-contingent test with out-of-pocket expense and, in turn, inform best practice by specifying the information that should be prioritized when providing pre-test counseling to women in a time-limited scenario or space-limited decision support tool. We asked women (N = 242) in Australia to indicate the importance of knowing 24 information items when making a decision about NIPT and to choose two information items they would most value. Our findings suggest that women value having complete information when making decisions about NIPT. Information about the accuracy of NIPT and the pros and cons of NIPT compared to other screening and invasive tests were perceived to be most important. The findings of this study can be used to maximize the usefulness of time-limited discussions or space-limited decision support tools, but should not be routinely relied upon as a replacement for provision of full and tailored information when feasible.

摘要

充分的知识是明智决策的重要组成部分;然而,我们并不清楚女性在做出关于无创产前检测(NIPT)的决策时看重哪些信息。当前的研究旨在确定女性在将NIPT作为一项自费的、非偶然性的一级检测进行决策时的信息需求,进而通过明确在时间有限的场景或空间有限的决策支持工具中向女性提供检测前咨询时应优先考虑的信息,为最佳实践提供参考。我们让澳大利亚的女性(N = 242)指出在做出关于NIPT的决策时了解24项信息的重要性,并选择她们最看重的两项信息。我们的研究结果表明,女性在做出关于NIPT的决策时重视获得完整的信息。与其他筛查和侵入性检测相比,NIPT的准确性以及NIPT的优缺点方面的信息被认为是最重要的。本研究的结果可用于最大限度地提高时间有限的讨论或空间有限的决策支持工具的效用,但在可行的情况下,不应常规地依赖这些结果来替代提供全面且量身定制的信息。

相似文献

1
Talking Points: Women's Information Needs for Informed Decision-Making About Noninvasive Prenatal Testing for Down Syndrome.要点:女性对于唐氏综合征无创产前检测知情决策的信息需求
J Genet Couns. 2018 Sep;27(5):1258-1264. doi: 10.1007/s10897-018-0250-8. Epub 2018 Mar 17.
2
Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.促进非侵入性产前检测(NIPT)知情选择:对女性体验的系统评价和定性元分析。
BMC Pregnancy Childbirth. 2019 Jan 14;19(1):27. doi: 10.1186/s12884-018-2168-4.
3
Improving women's knowledge about prenatal screening in the era of non-invasive prenatal testing for Down syndrome - development and acceptability of a low literacy decision aid.提高唐氏综合征非侵入性产前检测时代女性对产前筛查的认知——低文化程度决策辅助工具的开发与可接受性。
BMC Pregnancy Childbirth. 2018 Dec 17;18(1):499. doi: 10.1186/s12884-018-2135-0.
4
Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.产科专业人士对非侵入性产前唐氏综合征筛查的看法:与现有检测方法相比的临床效用及伦理影响。
BMC Pregnancy Childbirth. 2017 Sep 5;17(1):285. doi: 10.1186/s12884-017-1474-6.
5
Women's Attitudes Toward Invasive and Noninvasive Testing When Facing a High Risk of Fetal Down Syndrome.当面临胎儿唐氏综合征高风险时,女性对有创性和非侵入性检测的态度。
JAMA Netw Open. 2019 Mar 1;2(3):e191062. doi: 10.1001/jamanetworkopen.2019.1062.
6
Decision outcomes in women offered noninvasive prenatal test (NIPT) for positive Down screening results.唐氏筛查结果呈阳性的女性接受无创产前检测(NIPT)后的决策结果。
J Matern Fetal Neonatal Med. 2019 Jan;32(2):348-350. doi: 10.1080/14767058.2017.1378323. Epub 2017 Sep 19.
7
The influence of experiential knowledge and societal perceptions on decision-making regarding non-invasive prenatal testing (NIPT).经验知识和社会观念对非侵入性产前检测(NIPT)决策的影响。
BMC Pregnancy Childbirth. 2020 Oct 19;20(1):630. doi: 10.1186/s12884-020-03203-4.
8
'Small cost to pay for peace of mind': Women's experiences with non-invasive prenatal testing.“为安心付出的小代价”:女性的无创产前检测经历
Aust N Z J Obstet Gynaecol. 2019 Oct;59(5):649-655. doi: 10.1111/ajo.12945. Epub 2019 Feb 6.
9
What are women saying about noninvasive prenatal testing? An analysis of online pregnancy discussion forums.女性对无创性产前检测有何看法?对在线妊娠讨论论坛的分析。
Prenat Diagn. 2019 Sep;39(10):890-895. doi: 10.1002/pd.5500. Epub 2019 Jun 18.
10
Decision-making for non-invasive prenatal testing for Down syndrome: Hong Kong Chinese women's preferences for individual vs relational autonomy.唐氏综合征无创产前检测的决策:中国香港女性对个体自主与关系自主的偏好
Clin Genet. 2016 May;89(5):550-6. doi: 10.1111/cge.12743. Epub 2016 Mar 4.

引用本文的文献

1
Women's experiences with non-invasive prenatal testing in Switzerland: a qualitative analysis.瑞士女性对非侵入性产前检测的体验:定性分析。
BMC Med Ethics. 2023 Oct 23;24(1):85. doi: 10.1186/s12910-023-00964-3.
2
Informed choice of pregnant women regarding noninvasive prenatal testing in Korea: a cross-sectional study.韩国孕妇对无创产前检测的知情选择:一项横断面研究。
Korean J Women Health Nurs. 2022 Sep;28(3):235-249. doi: 10.4069/kjwhn.2022.09.10. Epub 2022 Sep 30.
3
External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days.

本文引用的文献

1
Implementing non-invasive prenatal testing for aneuploidy in a national healthcare system: global challenges and national solutions.在国家医疗体系中实施非侵入性产前基因检测以筛查染色体非整倍体:全球挑战与国家解决方案
BMC Health Serv Res. 2017 Sep 19;17(1):670. doi: 10.1186/s12913-017-2618-0.
2
Offering non-invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained?作为常规临床服务的一部分提供非侵入性产前检测。能否保持高水平的知情选择?
Prenat Diagn. 2017 Nov;37(11):1130-1137. doi: 10.1002/pd.5154. Epub 2017 Oct 17.
3
Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives.
基于 105-139 天的 87 例母血清样本,对甲胎蛋白、游离β-人绒毛膜促性腺激素和未结合雌三醇进行检测,以评估其在检测唐氏综合征和神经管缺陷中的外部质量。
Med Sci Monit. 2022 Apr 13;28:e935573. doi: 10.12659/MSM.935573.
4
The influence of experiential knowledge and societal perceptions on decision-making regarding non-invasive prenatal testing (NIPT).经验知识和社会观念对非侵入性产前检测(NIPT)决策的影响。
BMC Pregnancy Childbirth. 2020 Oct 19;20(1):630. doi: 10.1186/s12884-020-03203-4.
5
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.在中国一个试点城市,非侵入性产前检测在 21 三体、18 三体、13 三体和性染色体非整倍体的一线筛查中表现出良好的临床性能。
Hum Genomics. 2020 Jun 5;14(1):21. doi: 10.1186/s40246-020-00268-2.
6
Consensus on priorities in maternal education: results of Delphi and nominal group technique approaches.产妇教育重点的共识:德尔菲法和名义群体技术方法的结果。
BMC Pregnancy Childbirth. 2019 Jul 24;19(1):264. doi: 10.1186/s12884-019-2382-8.
7
Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.公共和私立医疗保健部门唐氏综合征无创产前检测的服务提供:一项针对产科医护人员的定性研究
BMC Health Serv Res. 2018 Sep 21;18(1):731. doi: 10.1186/s12913-018-3540-9.
荷兰实验室对无创产前检测进行评估的试验。第二部分——女性视角。
Prenat Diagn. 2016 Dec;36(12):1091-1098. doi: 10.1002/pd.4941. Epub 2016 Nov 16.
4
Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.评估新加坡女性和医疗保健专业人员对实施唐氏综合征无创产前检测的偏好。
Singapore Med J. 2017 Jun;58(6):298-310. doi: 10.11622/smedj.2016114. Epub 2016 Jun 29.
5
The effect of a decision aid on informed decision-making in the era of non-invasive prenatal testing: a randomised controlled trial.决策辅助工具在无创产前检测时代对知情决策的影响:一项随机对照试验。
Eur J Hum Genet. 2016 Oct;24(10):1409-16. doi: 10.1038/ejhg.2016.39. Epub 2016 May 18.
6
NIPT and Informed Consent: an Assessment of Patient Understanding of a Negative NIPT Result.无创产前检测(NIPT)与知情同意:对患者对NIPT阴性结果理解情况的评估
J Genet Couns. 2016 Oct;25(5):1127-37. doi: 10.1007/s10897-016-9945-x. Epub 2016 Apr 1.
7
Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy.非整倍体无创产前检测女性知情选择量表的编制与验证
Eur J Hum Genet. 2016 Jun;24(6):809-16. doi: 10.1038/ejhg.2015.207. Epub 2015 Oct 28.
8
Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.第640号委员会意见:游离DNA筛查胎儿非整倍体。
Obstet Gynecol. 2015 Sep;126(3):e31-e37. doi: 10.1097/AOG.0000000000001051.
9
Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective.基于2015年的视角:使用游离DNA进行无创产前检测的推荐检测前咨询要点
Prenat Diagn. 2015 Oct;35(10):968-71. doi: 10.1002/pd.4666. Epub 2015 Sep 3.
10
It's More Than a Blood Test: Patients' Perspectives on Noninvasive Prenatal Testing.这不仅仅是一项血液检测:患者对无创产前检测的看法。
J Clin Med. 2014 Jun 19;3(2):614-31. doi: 10.3390/jcm3020614.